Dosage ;
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Cardiopril | Dr. Reddys Laboratories Ltd. | Surgilinks Ltd. | 2.5mg | 20 | Tablet | per tablet | KES 240 |
| Cardiopril | Dr. Reddys Laboratories Ltd. | Surgilinks Ltd. | 5mg | 20 | Tablet | per tablet | KES 400 |
| Cardiopril | Dr. Reddys Laboratories Ltd. | Surgilinks Ltd. | 10mg | 20 | Tablet | per tablet | KES 640 |
| Tritace | Sanofi Aventis | Surgipharm Ltd | 2.5mg | 30 | Tablet | per tablet | KES 1,297.00 |
| Tritace | Sanofi Aventis | Surgipharm Ltd | 5mg | 30 | Tablet | per tablet | KES 2,224.00 |
| Tritace | Sanofi Aventis | Surgipharm Ltd | 10mg | 30 | Capsule | per capsule | KES 2,514.00 |
| Variace | Win-Medicare | Europa Healthcare Ltd. | 1.25mg | 30 | Tablet | per tablet | KES 390 |
| Variace | Win-Medicare | Europa Healthcare Ltd. | 2.5mg | 30 | Tablet | per tablet | KES 1,350.00 |
| Variace | Win-Medicare | Europa Healthcare Ltd. | 5mg | 30 | Tablet | per tablet | KES 1,870.00 |
| Ramitace | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 2.5mg | 30 | Tablet | per tablet | KES 600.00 |
| Ramitace | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 5mg | 30 | Tablet | per tablet | KES 900.00 |
| Ramitace | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 10mg | 30 | Tablet | per tablet | KES 1,200.00 |
| Ramitas | Intas Pharmaceuticals Ltd | Medisel Kenya Ltd | 2.5mg | 30 | Tablet | per tablet | KES 750.00 |
| Ramitas | Intas Pharmaceuticals Ltd | Medisel Kenya Ltd | 5mg | 30 | Tablet | per tablet | KES 1,150.00 |
| Ramipril More info | |||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mode Of Action | Inhibition of the conversion of angiotensin I to angiotensin II. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Indication | Mild to moderate hypertension; CHF; myocardial infarction. | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Precautions | Severe CCF, impaired renal function, lactation, aortic stenosis, NSAIDs, monitor serum lithium levels, first dose may cause hypotension especially in dehydrated cases, low sodium serum levels, diuretic treated cases, monitor renal function, may potentiate hypoglyceamic effects of insulin or oral hypoglycaemic agents, haematological monitoring. Avoid potassium sparing diuretics or potassium supplements. | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Contra-Indications | Pregnancy, history of angioneurotic oedema with previous ACE inhibitors, hypersensitivity, renal vascular disease, porphyria. | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Side Effects | Persistent dry cough, voice changes, chest pain, taste disturbances, bronchospasm, blood dyscrasias, tachycardia, increased serum potassium levels, anaphylactic reactions, hepatic /renal impairment, hypotension, GI disturbances, muscle cramps, sleep disturbances, flushing, asthenia, impotence, CVS disorders. | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Dosage | Dose: 1.25mg daily, increased at the interval of 1-2 wks (max. 10mg daily) after meals. | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Pregnancy Category | Category D | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Pregnancy Category Description | Drugs, which have caused, are suspected to have caused, or may be expected to cause an increased rise in the frequency of malformations or irreversible damage. These drugs may also have adverse pharmacological effects required required | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Sub-Category | Angiotensin-converting enzyme inhibitors
Combinations ;
|
||||||||||||||||||||||||||||||||||||||||||||||||||